Absence of Liner Following the Selective Caries Removal (ALFSCaRe)

Sponsor
Universidade Federal de Sergipe (Other)
Overall Status
Recruiting
CT.gov ID
NCT03933176
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other), Federal University of Pelotas (Other), University of Brasilia (Other), Universidade Federal do Ceara (Other), Federal University of Uberlandia (Other), Universidade Veiga de Almeida (Other)
340
1
2
62.1
5.5

Study Details

Study Description

Brief Summary

This randomized, multi-centric, controlled clinical trial will assess the effectiveness of a simplified restorative protocol used after the selective carious tissue removal in posterior teeth presenting deep carious lesions. Only a regular bulk-fill composite will be used in the simplified restorative protocol following the application of universal adhesive. A liner with resin-modified glass ionomer will be used over the pulpal floor before the composite placement in the control group. The longevity of restorative procedures and post-operative sensitivity were defined as the main and secondary outcomes.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Restoration of carious lesions
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
340 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Is the Use of a Glass Ionomer Liner Necessary After Selective Carious Tissue Removal?
Actual Study Start Date :
Jun 30, 2019
Actual Primary Completion Date :
Nov 1, 2020
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Simplified restorative procedure

After selective carious tissue removal, the universal adhesive (Adper Universal; 3M ESPE, St. Paul, MN, EUA) will be applied on the cavity walls. The cavity will be restored using a single increment of Filtek One Bulk Fill (3M ESPE, St. Paul, MN, EUA).

Procedure: Restoration of carious lesions
Selective carious tissue removal followed by restoration of the cavity using composite resin.

Active Comparator: Control

A thin layer of resin-modified glass ionomer (Ionoseal (Voco America Inc., Briarcliff Manor, NY, EUA) will be placed on the pulpal floor of the cavity. Then, the adhesive and composite will be used following the same directions defined for the experimental condition.

Procedure: Restoration of carious lesions
Selective carious tissue removal followed by restoration of the cavity using composite resin.

Outcome Measures

Primary Outcome Measures

  1. Longevity of restoration [Annual evaluation during 5 years]

    Assessment of any failure in restorations according to the FDI World Dental Federation criteria.

Secondary Outcome Measures

  1. Tooth sensitivity [15 days after the restorative procedure]

    The participants will self-assess their level of tooth sensitivity of the restored teeth using a visual analogue scale of 0-10 (0 indicating absence of pain; and 10 the worst pain possible) oriented by both verbal description and Wong-Baker facial grimace scales.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Molar presenting deep carious lesion;
Exclusion Criteria:
  • Non-vital teeth or teeth presenting pulpitis;

  • Cavity margins in dentin;

  • Presence of non-carious cervical lesions;

  • The necessity of restoration involving any cusp replacement.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Dentistry/ Federal University of Sergipe Aracaju SE Brazil 49060100

Sponsors and Collaborators

  • Universidade Federal de Sergipe
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Federal University of Pelotas
  • University of Brasilia
  • Universidade Federal do Ceara
  • Federal University of Uberlandia
  • Universidade Veiga de Almeida

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
André Luis Faria e Silva, Professor, Universidade Federal de Sergipe
ClinicalTrials.gov Identifier:
NCT03933176
Other Study ID Numbers:
  • UFS/Prodonto
First Posted:
May 1, 2019
Last Update Posted:
Nov 12, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by André Luis Faria e Silva, Professor, Universidade Federal de Sergipe

Study Results

No Results Posted as of Nov 12, 2020